Skip to content

Effects of Allergen Inhalation on Adenosine Receptor Expression in Sputum and Peripheral Blood

Effects of Allergen Inhalation on Adenosine Receptor Expression and Mast Cell Activation in Peripheral Blood and Sputum of Asthmatics and Healthy Subjects

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00116311
Enrollment
20
Registered
2005-06-29
Start date
2005-07-31
Completion date
2007-02-28
Last updated
2007-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma, Healthy

Keywords

Adenosine receptors, asthma, sputum, peripheral blood, healthy

Brief summary

The purpose of this study is to determine whether asthmatics have different adenosine receptor expression profiles than healthy controls. We hypothesize that asthmatics will have increased adenosine receptor expression versus control subjects. We also want to study the effects of allergen inhalation on adenosine receptor expression in asthmatics. We believe that adenosine receptor expression will be upregulated after allergen inhalation. Both hypotheses are being tested in sputum and peripheral blood.

Interventions

BEHAVIORALallergen inhalation

Sponsors

Groningen Research Institute for Asthma and COPD
Lead SponsorOTHER

Study design

Observational model
DEFINED_POPULATION
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

Asthmatic Subjects - Inclusion Criteria: * Clinical diagnosis of asthma * Steroid naive or subjects not using their inhaled steroids for the last 4 weeks, short-acting beta-agonist for rescue medication * FEV1 \> 70% of predicted * Positive skin prick test for house dust mite, cat or grass pollen * PC20 methacholine or histamine \< 8 mg/ml Asthmatic Subjects -

Exclusion criteria

* Use of systemic steroids in the previous 6 weeks * Asthma exacerbations in the previous 6 weeks * Current or ex-smokers with ≥ 10 pack-years (≥ 2 pipe pack-years), ex smokers who stopped less than 1 year ago Healthy Subjects - Inclusion Criteria: * No airway complaints * FEV1 \> 90% of predicted * Negative skin prick test * PC20 methacholine or histamine \> 8 mg/ml Healthy Subjects -

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026